Good Morning Wake-Up Watchlisters! Grab the fruit-infused summer latte and check out this week's morning premarket report. Below you'll see indexes were flat on Wednesday after the S&P 500 closed above 5,500 for the first time ever. However, investors are concerned the rally can only last for so long and a pullback may be imminent. While the news media creates uncertainty around the markets, our Lead Technical Tactician Nate Bear knows pullbacks are a normal part of trading. It's why he uses the "post-earnings surge" pattern in Profit Surge Trader to find high probability trades that have a chance at dealing outsized returns. This patient, measured approach has led to a 79% win rate overall, including an 26.57% gain last week on MPC. Click here to access Nate's latest One Ticker Payout trade for July. Here's a look at the top-moving stocks this morning. CureVac (Nasdaq: CVAC) CureVac is up 23.35% in premarket trading after British drugmaker GSK reached an agreement to buy the rights to CureVac's Covid-19 and flu vaccines for up to $1.56 billion. CureVac also said it would be reduce its workforce by 30% as it focuses on mRNA-based cancer therapies and other earlier-stage projects. Simulations Plus (Nasdaq: SLP) Simulations Plus is down 6.68% in premarket trading after suspending its quarterly dividend as part of a plan to reallocate resources towards growth. The final dividend of 6 cents a share will be paid on Aug. 5 to shareholders of record of July 29. It also reported third-quarter adjusted earnings of 19 cents a share that topped analysts' estimates. |
No comments:
Post a Comment